Cite
HARVARD Citation
Fajgenbaum, D. et al. (n.d.). Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease. Immunotherapy. pp. 17-26. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fajgenbaum, D. et al. (n.d.). Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease. Immunotherapy. pp. 17-26. [Online].